Medicenna Extends Period to Exercise Certain Warrants : comp

TORONTO and HOUSTON, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical...

Related Keywords

Toronto , Ontario , Canada , Houston , Texas , United States , Superkine Immunotherapies , Christina Cameron , Twitter , Toronto Stock Exchange , Linkedin , Medicenna Therapeutics Corp , Common Share , Orphan Drug , Targeted Metalloprotease Activated Superkine , Annual Report , Toronto Stock Exchange Mdna ,